Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 118

1.

Severe hypercalcemia following vitamin d supplementation in a patient with multiple sclerosis: a note of caution.

Marcus JF, Shalev SM, Harris CA, Goodin DS, Josephson SA.

Arch Neurol. 2012 Jan;69(1):129-32. doi: 10.1001/archneurol.2011.1199.

PMID:
22232355
2.

Acute hypercalcemia following excessive calcium supplementation in a dehydrated patient with progressive multiple sclerosis: vitamin D supplementation is a red herring.

Hanwell HE, Kimball SM.

Arch Neurol. 2012 Jun;69(6):793; author reply 793-4. doi: 10.1001/archneurol.2012.200. No abstract available.

PMID:
22689201
3.

Safety of vitamin D3 in adults with multiple sclerosis.

Kimball SM, Ursell MR, O'Connor P, Vieth R.

Am J Clin Nutr. 2007 Sep;86(3):645-51.

4.

Suppressibility of parathyroid hormone in primary hyperparathyroidism.

Khoo TK, Baker CH, Abu-Lebdeh HS, Wermers RA.

Endocr Pract. 2007 Nov-Dec;13(7):785-9.

PMID:
18194938
5.

Incidence of hypercalciuria and hypercalcemia during vitamin D and calcium supplementation in older women.

Gallagher JC, Smith LM, Yalamanchili V.

Menopause. 2014 Nov;21(11):1173-80. doi: 10.1097/GME.0000000000000270.

6.

A patient with severe hypercalcemia in multiple organ dysfunction syndrome: role of elevated circulating 1alpha,25(OH)2 vitamin D levels.

Kazama JJ, Yamamoto T, Oya H, Yamamoto S, Sato Y, Sakurada J, Honda T, Endoh H, Narita I.

J Bone Miner Res. 2010 Jun;25(6):1455-9. doi: 10.1002/jbmr.18.

7.

Hypervitaminosis D associated with a vitamin D dispensing error.

Jacobsen RB, Hronek BW, Schmidt GA, Schilling ML.

Ann Pharmacother. 2011 Oct;45(10):e52. doi: 10.1345/aph.1Q330. Epub 2011 Sep 13.

PMID:
21917555
8.

High-dose oral vitamin D3 supplementation in rheumatology patients with severe vitamin D3 deficiency.

von Restorff C, Bischoff-Ferrari HA, Theiler R.

Bone. 2009 Oct;45(4):747-9. doi: 10.1016/j.bone.2009.06.012. Epub 2009 Jun 17.

PMID:
19539796
9.

Hypercalcemia and acute kidney injury caused by abuse of a parenteral veterinary compound containing vitamins A, D, and E.

Rocha PN, Santos CS, Avila MO, Neves CL, Bahiense-Oliveira M.

J Bras Nefrol. 2011 Dec;33(4):467-71.

10.

Impact of cholecalciferol treatment on biomarkers of inflammation and myocardial structure in hemodialysis patients without hyperparathyroidism.

Bucharles S, Barberato SH, Stinghen AE, Gruber B, Piekala L, Dambiski AC, Custodio MR, Pecoits-Filho R.

J Ren Nutr. 2012 Mar;22(2):284-91. doi: 10.1053/j.jrn.2011.07.001. Epub 2011 Sep 10.

PMID:
21908203
11.

Vitamin D intoxication due to an erroneously manufactured dietary supplement in seven children.

Kara C, Gunindi F, Ustyol A, Aydin M.

Pediatrics. 2014 Jan;133(1):e240-4. doi: 10.1542/peds.2013-0711. Epub 2013 Dec 2.

12.

Vitamin D toxicity due to a commonly available "over the counter" remedy from the Dominican Republic.

Lowe H, Cusano NE, Binkley N, Blaner WS, Bilezikian JP.

J Clin Endocrinol Metab. 2011 Feb;96(2):291-5. doi: 10.1210/jc.2010-1999. Epub 2010 Dec 1.

PMID:
21123442
13.

Risk of hypercalcemia in blacks taking hydrochlorothiazide and vitamin D.

Chandler PD, Scott JB, Drake BF, Ng K, Forman JP, Chan AT, Bennett GG, Hollis BW, Giovannucci EL, Emmons KM, Fuchs CS.

Am J Med. 2014 Aug;127(8):772-8. doi: 10.1016/j.amjmed.2014.02.044. Epub 2014 Mar 20.

14.

A longitudinal study of serum 25-hydroxyvitamin D and intact parathyroid hormone levels indicate the importance of vitamin D and calcium homeostasis regulation in multiple sclerosis.

Soilu-Hänninen M, Laaksonen M, Laitinen I, Erälinna JP, Lilius EM, Mononen I.

J Neurol Neurosurg Psychiatry. 2008 Feb;79(2):152-7. Epub 2007 Jun 19.

PMID:
17578859
16.

Acute vitamin D intoxication possibly due to faulty production of a multivitamin preparation.

Anık A, Çatlı G, Abacı A, Dizdarer C, Böber E.

J Clin Res Pediatr Endocrinol. 2013;5(2):136-9. doi: 10.4274/Jcrpe.896.

17.

Recurrent pancreatitis secondary to hypercalcemia following vitamin D poisoning.

Waele BD, Smitz J, Willems G.

Pancreas. 1989;4(3):378-80.

PMID:
2471970
18.

Efficacy and safety of oral continuous low-dose versus short-term high-dose vitamin D: a prospective randomised trial conducted in a clinical setting.

Hackman KL, Gagnon C, Briscoe RK, Lam S, Anpalahan M, Ebeling PR.

Med J Aust. 2010 Jun 21;192(12):686-9.

PMID:
20565345
19.
20.

Pattern of 25-hydroxy vitamin D response at short (2 month) and long (1 year) interval after 8 weeks of oral supplementation with cholecalciferol in Asian Indians with chronic hypovitaminosis D.

Goswami R, Gupta N, Ray D, Singh N, Tomar N.

Br J Nutr. 2008 Sep;100(3):526-9. doi: 10.1017/S0007114508921711. Epub 2008 Feb 6.

PMID:
18252022
Items per page

Supplemental Content

Write to the Help Desk